Yu Xuxia, Zhang Danyang, Song Qifa
Department of Hospital Infection, Ningbo City First Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Department of Microbiology, Ningbo Municipal Centre for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Infect Drug Resist. 2020 Jul 12;13:2285-2290. doi: 10.2147/IDR.S257877. eCollection 2020.
Fluoroquinolone-resistant is considered a serious public health problem and has been put on the WHO global priority list of antibiotic-resistant bacteria. This study was aimed to investigate the fluoroquinolone resistance in and its relevant genetic mechanisms.
isolates that were isolated from diarrheal patient's feces in Ningbo China from 2011 to 2018 were tested for susceptibility to ampicillin, gentamicin, tetracycline, nalidixic acid, ciprofloxacin, and cefotaxime. Genes related to quinolone resistance were amplified by PCR.
A total of 118 isolates were collected, including 76 isolates, 40 isolates, and 2 isolates. Ciprofloxacin susceptibility test identified 10 (9%) susceptible, 65 (55%) intermediate, and 43 (36%) resistant isolates. Of 76 isolates, 37 were ciprofloxacin resistant, a prevalence significantly higher than 6 of 40 isolates (=0.01). The isolates collected during 2014-2018 displayed a significant increase in the prevalence of ciprofloxacin resistance (=0.05) than those collected during 2011-2013. All the ciprofloxacin-intermediate and resistant isolates had mutations of (S83L) and (S80I), whereas only the ciprofloxacin-resistant isolates had (D87N) mutation and gene. Additionally, 30% of the ciprofloxacin-resistant isolates were positive for gene.
This study shows the currently increasing prevalence of ciprofloxacin resistance. The reduced fluoroquinolone susceptibility is highly associated with (S83L) and (S80I) mutations, while the fluoroquinolone resistance is highly associated with (D87N) mutation, gene and perhaps gene.
氟喹诺酮耐药被认为是一个严重的公共卫生问题,已被列入世界卫生组织抗生素耐药细菌全球优先清单。本研究旨在调查[具体细菌名称未给出]中的氟喹诺酮耐药情况及其相关遗传机制。
对2011年至2018年从中国宁波腹泻患者粪便中分离出的[具体细菌名称未给出]菌株进行氨苄西林、庆大霉素、四环素、萘啶酸、环丙沙星和头孢噻肟的药敏试验。通过PCR扩增与喹诺酮耐药相关的基因。
共收集到118株[具体细菌名称未给出]菌株,包括76株[具体细菌名称未给出]菌株、40株[具体细菌名称未给出]菌株和2株[具体细菌名称未给出]菌株。环丙沙星药敏试验鉴定出10株(9%)敏感、65株(55%)中介和43株(36%)耐药菌株。在76株[具体细菌名称未给出]菌株中,37株对环丙沙星耐药,其流行率显著高于40株[具体细菌名称未给出]菌株中的6株(P = 0.01)。2014 - 2018年收集的菌株中环丙沙星耐药流行率比2011 - 2013年收集的菌株显著增加(P = 0.05)。所有环丙沙星中介和耐药菌株均有具体基因名称未给出和具体基因名称未给出突变,而只有环丙沙星耐药菌株有具体基因名称未给出突变和[具体基因名称未给出]基因。此外,30%的环丙沙星耐药菌株[具体基因名称未给出]基因呈阳性。
本研究表明目前环丙沙星耐药流行率正在上升。氟喹诺酮敏感性降低与具体基因名称未给出和具体基因名称未给出突变高度相关,而氟喹诺酮耐药与具体基因名称未给出突变、[具体基因名称未给出]基因以及可能的[具体基因名称未给出]基因高度相关。